VHL-mediated disruption of Sox9 activity compromises β-cell identity and results in diabetes mellitus

Genes Dev. 2013 Dec 1;27(23):2563-75. doi: 10.1101/gad.227785.113.

Abstract

Precise functioning of the pancreatic β cell is paramount to whole-body glucose homeostasis, and β-cell dysfunction contributes significantly to diabetes mellitus. Using transgenic mouse models, we demonstrate that deletion of the von Hippel-Lindau (Vhlh) gene (encoding an E3 ubiquitin ligase implicated in, among other functions, oxygen sensing in pancreatic β cells) is deleterious to canonical β-cell gene expression. This triggers erroneous expression of factors normally active in progenitor cells, including effectors of the Notch, Wnt, and Hedgehog signaling cascades. Significantly, an up-regulation of the transcription factor Sox9, normally excluded from functional β cells, occurs upon deletion of Vhlh. Sox9 plays important roles during pancreas development but does not have a described role in the adult β cell. β-Cell-specific ectopic expression of Sox9 results in diabetes mellitus from similar perturbations in β-cell identity. These findings reveal that assaults on the β cell that impact the differentiation state of the cell have clear implications toward our understanding of diabetes mellitus.

Keywords: dedifferentiation; diabetes mellitus; hypoxia; von-Hippel Lindau; β cell.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Hypoxia / physiology
  • Cell Line
  • Diabetes Mellitus / genetics*
  • Diabetes Mellitus / physiopathology*
  • Gene Deletion
  • Gene Expression Regulation / genetics*
  • Humans
  • Insulin-Secreting Cells / cytology*
  • Insulin-Secreting Cells / metabolism
  • Male
  • Mice
  • SOX9 Transcription Factor / metabolism*
  • Von Hippel-Lindau Tumor Suppressor Protein / genetics
  • Von Hippel-Lindau Tumor Suppressor Protein / metabolism*

Substances

  • SOX9 Transcription Factor
  • Von Hippel-Lindau Tumor Suppressor Protein